Search
Showing results for "1"
Research
Seasonal variation in fetal growth: Accounting for sociodemographic, biological, and environmental exposuresWe sought to investigate seasonal variation in fetal growth, accounting for important sociodemographic, biological, and environmental exposures.
The Opportunity The Kids Research Institute Australia’s Drug Discovery Unit is working at the cutting-edge of peptide-based drug discovery. The
This newly created position will provide a PhD graduate with the opportunity to join the Autism Research Team as a Research Assistant
Preventing over half of the world’s ear infections with a therapy such as Spritz-OM will significantly improve health and educational outcomes on a global scale.
News & Events
Hybrid system gets big thumbs up from AndrewJust a small taste of the hybrid closed loop pump was all it took for Andrew Parsons to jump at the chance to be involved in a longer at-home trial of the system.
Research
Cellulitis in children: A retrospective single centre study from AustraliaTo characterise the epidemiology, clinical features and treatment of paediatric cellulitis. Methods A retrospective study of children presenting to a paediatric tertiary hospital in Western Australia, Australia in 2018.
Research
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Jonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@
Research
Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile InfectionJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
A Phase II Randomized, Controlled, Observer-Blinded Study, Conducted to Describe the Immunogenicity, Safety, and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine When Administered to Healthy ToddlersJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Publications, papers and findings coming out of ORIGINS and its sub-projects